Menstrual cycle disorders after therapy with iodine-131

Fertility and Sterility

Volumn 86, Issue 3, 2006, Pages 625-628

  Sioka, Chrissa ^a   Kouraklis, Gregory ^b   Zafirakis, Athanasios ^c   Manetou, Angeliki ^a   Dimakopoulos, Nikolaos ^a  

^a 417 Army Share Found Hospital   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

Author keywords

I 131; menstrual cycle; pregnancy; thyroid cancer

Indexed keywords

IODINE 131;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; GYNECOLOGY; HUMAN; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; SPONTANEOUS ABORTION; THYROID CANCER; TIME SERIES ANALYSIS;

ADULT; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; GREECE; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; MENSTRUAL CYCLE; MENSTRUATION DISTURBANCES; PREGNANCY; PREGNANCY OUTCOME; RADIATION INJURIES; RISK ASSESSMENT; RISK FACTORS; THYROID NEOPLASMS;

EID: 33748109399     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.02.081     Document Type: Article

References (10)

1. Bonnin C., Trojani M., Corcuff J.B., and Bonichon F. Outcome of 111 thyroid papillary carcinomas. Retrospective study from 1953 to 1994. Experience of Bergonie Institute. Ann Endocrinol (Paris) 58 (1997) 318-325
2. Coburn M., Teates D., and Wanebo H.J. Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131). Ann Surg 21 (1994) 587-593
3. Raymond J.P., Izembart M., Marliac V., Dagousset F., Merceron R.E., Vulpillat M., et al. Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine. J Clin Endocrinol Metab 69 (1989) 186-190
4. Dottorini M.E., Lomuscio G., Mazzucchelli L., Vignati A., and Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 36 (1995) 21-27
5. Izembart M., Chavaudra J., Aubert B., and Vallee G. Retrospective evaluation of the dose received by the ovary after radioactive iodine therapy for thyroid cancer. Eur J Nucl Med 19 (1992) 243-247
6. Vini L., Hyer S., Al-Saadi A., Pratt B., and Harmer C. Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer. Postgrad Med J 78 (2002) 92-93
7. Schlumberger M., De Vathaire F., Ceccarelli C., Delisle M.J., Francese C., Couette J.E., et al. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 37 (1996) 606-612
8. Lazarus J.H. Thyroid dysfunction: reproduction and postpartum thyroiditis. Semin Reprod Med 20 (2002) 381-388
9. Ehrenheim C., Hauswirth C., Fitschen J., Martin E., Oetting G., and Hundeshagen H. Genetic risk after high dose radioiodine therapy with regard to gonadal dose. Nuklearmedizin 36 (1997) 157-166
10. Arndt D., Mehnert W.H., Franke W.G., Woller P., Laude G., Rockel A., et al. Radioiodine therapy during an unknown remained pregnancy and radiation exposure of the fetus. A case report. Strahlenther Onkol 170 (1994) 408-414